Download Annual Report 2012 - Drees & Sommer
Download Annual Report 2012 - Drees & Sommer
Download Annual Report 2012 - Drees & Sommer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ConstruCtion of new a researCH Center<br />
Laboratories and offices are located behind<br />
the transparent glass facade<br />
Octapharma<br />
creates space<br />
for research &<br />
development in<br />
Heidelberg<br />
The biotechnology specialist completed its new Research Center in Heidelberg on schedule<br />
in October <strong>2012</strong>. Some 50 employees undertake research into recombinant plasma products<br />
in the vicinity of major medical and clinical facilities. <strong>Drees</strong> & <strong>Sommer</strong> life sciences experts<br />
supported the project during the planning and construction phases.<br />
Thanks to its offices in Munich and<br />
Stuttgart, <strong>Drees</strong> & <strong>Sommer</strong> was close<br />
at hand while supporting planning in<br />
Martinsried and the subsequent tender<br />
process and realization in Heidelberg.<br />
This separation of tasks made it possible<br />
for Octapharma to continue to focus<br />
on research, while the project managers<br />
controlled processes on the construction<br />
site. That was particularly important as<br />
the new building was to set the standard<br />
for the company’s future buildings.<br />
plenty of space in the future, too<br />
In future, Heidelberg will not only undertake<br />
innovative research in the field of<br />
recombinant proteins, but also promote<br />
the development and clinical production<br />
of new medicines. A feature of the new<br />
building is a six-meter high room<br />
that can accommodate a 1,000-liter<br />
fermenter for production. It also houses<br />
a laboratory and office facilities for up<br />
to 120 employees. Expansion areas<br />
are primarily located on the third floor,<br />
with GMP-compliant laboratories<br />
taking up most of the first (ground)<br />
and second floors.<br />
<strong>Drees</strong> & <strong>Sommer</strong> impressed clients<br />
with its professional work: In Dessau,<br />
colleagues from the Leipzig office are<br />
already supporting Octapharma’s<br />
next expansion project.<br />
Client<br />
Octapharma Biopharmaceuticals GmbH,<br />
Heidelberg<br />
project duration<br />
January 2010 – October <strong>2012</strong><br />
architects<br />
Burger Architekten und Partner, Heidelberg<br />
Key project data<br />
– GFA: 10,625 m 2<br />
– Cost: € 25 million net<br />
drees & sommer services<br />
– Project control and project management<br />
– Project Communication System (PCS)<br />
value-add achieved for client<br />
– Adherence to budget<br />
– On-schedule consolidation of all employees<br />
at the Heidelberg site<br />
– Technical optimization of construction<br />
processes and use of state-of-the-art<br />
building materials<br />
– Extraction and consolidation of<br />
different locations’ specifications<br />
to establish new standards for this and<br />
future construction projects<br />
Office area<br />
Laboratory area<br />
With some 4,500 employees, Octapharma<br />
has specialized in development, production<br />
and sale of high-quality preparations<br />
derived from human plasma and human<br />
cell lineages. The products help patients<br />
with coagulation disorders and immunodeficiency<br />
in over 80 countries, and<br />
modern intensive care and emergency<br />
medical treatment are unthinkable<br />
without them.<br />
The company now has production<br />
facilities at five sites in Austria, France,<br />
Germany, Sweden and Mexico. Octapharma<br />
Biopharmaceuticals GmbH<br />
was founded in 1997. With premises of<br />
just 1,400 square meters in Martinsried<br />
near Munich, the subsidiary has recorded<br />
a steady growth since its foundation.<br />
new site for further growth<br />
In 2009, production capacity in Martinsried<br />
was too small and urgently needed<br />
space for growth was not available at<br />
the site. For this reason, the company<br />
gravitated towards the Rhine-<br />
Neckar region – a booming center<br />
for the life sciences-industry.<br />
After examining several options,<br />
Octapharma acquired a building<br />
site in the Technology Park in Heidelberg,<br />
Germany. The new location offers<br />
plenty of space and is located close to<br />
prestigious medical and clinical<br />
institutions such as the German Cancer<br />
Research Center and the Heidelberg<br />
University Hospital.<br />
Customer proximity<br />
Thanks to <strong>Drees</strong> & <strong>Sommer</strong>’s many years<br />
of experience with projects in the life<br />
sciences industry, a team of experts<br />
from the company was commissioned<br />
to support the planning and realization<br />
of the 10,000 square meter new building.<br />
The special feature of the project was<br />
that the principal remained completely<br />
operational in Martinsried right up to<br />
the relocation in March <strong>2012</strong>.<br />
Documentation<br />
workplaces<br />
laboratory<br />
Office area<br />
Plan of the second floor of the new building,<br />
(Burger Architekten und Partner, Heidelberg)<br />
44 45